Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ABBOTT LABORATORIES
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 13.2M shares of ABT (ABBOTT LABORATORIES), worth $1.4B as of 2026-Q1. The position was increased (+19.4% shares). ABT represents 0.3% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$1.4B
Current Shares
13.2M
Total Value Change
+$335.6M
Total Shares Change
+3.4M
Other major holders of ABT: GQG Partners LLC, BNP PARIBAS FINANCIAL MARKETS
Increased |
| 13.2M |
+19.4% |
| $1.4B |
| 0.3% |
| $113.61 |
45 |
| 2025-Q4 | Increased | 11.1M | +5.8% | $1.4B | 0.3% | $125.15 | 40 |
| 2025-Q3 | Decreased | 10.5M | -18.0% | $1.4B | 0.3% | $131.85 | 0 |
| 2025-Q2 | Increased | 12.7M | +22.1% | $1.7B | 0.4% | $132.52 | 46 |
| 2025-Q1 | Decreased | 10.4M | -2.1% | $1.4B | 0.4% | $128.41 | 0 |
| 2024-Q4 | Increased | 10.7M | +15.5% | $1.2B | 0.3% | $110.14 | 44 |
| 2024-Q3 | Decreased | 9.2M | -5.9% | $1.1B | 0.3% | $109.27 | 0 |
| 2024-Q2 | Increased | 9.8M | +40.9% | $1B | 0.3% | $100.45 | 51 |